ORLANDO, FL, USA (UroToday.com) - No prospective, randomized comparative efficacy trial exists to guide treatment of definitively managed prostate cancer patients. Several non-randomized reports exist that suggest equivalence of outcome.
Despite this lack of non-randomized data, treatment selection varies nationally and we attempt to assess these patterns of use....Click here to enlarge and view the poster.
Click here to view session highlights written by a UroToday.com medical editor
Presented by Jay P. Ciezki, MD,1 Chandana A. Reddy, MS,1 James Ulchaker, MD,2 Kenneth Angermeier, MD,2 Kevin Stephans, MD,1 Rahul Tendulkar, MD,1 Nabil Chehade, MD,3 Andrew Altman, MD,3 Eric Klein, MD2 at the 2013 Genitourinary Cancers Symposium - February 14 - 16, 2013 - Rosen Shingle Creek - Orlando, Florida USA
1Department of Radiation Oncology, Cleveland Clinic; 2Glickman Urologic Institute, Cleveland Clinic; 3Department of Urology, Kaiser Permanente - Ohio
View Full 2013 GU Cancers Symposium Coverage